Raymond James Financial Inc. purchased a new stake in Cronos Group Inc. (NASDAQ:CRON - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 317,418 shares of the company's stock, valued at approximately $641,000. Raymond James Financial Inc. owned 0.08% of Cronos Group as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. SBI Securities Co. Ltd. bought a new stake in Cronos Group during the 4th quarter valued at $30,000. Jones Financial Companies Lllp grew its position in shares of Cronos Group by 64.5% in the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock valued at $34,000 after purchasing an additional 6,520 shares in the last quarter. Thompson Davis & CO. Inc. purchased a new position in shares of Cronos Group in the fourth quarter valued at $29,000. Janney Montgomery Scott LLC raised its stake in shares of Cronos Group by 72.2% during the 4th quarter. Janney Montgomery Scott LLC now owns 380,575 shares of the company's stock valued at $769,000 after purchasing an additional 159,575 shares during the period. Finally, SeaCrest Wealth Management LLC lifted its holdings in Cronos Group by 77.3% during the 4th quarter. SeaCrest Wealth Management LLC now owns 189,245 shares of the company's stock worth $382,000 after purchasing an additional 82,500 shares in the last quarter. 8.71% of the stock is currently owned by hedge funds and other institutional investors.
Cronos Group Stock Performance
NASDAQ CRON traded up $0.07 during trading hours on Friday, hitting $1.75. The company had a trading volume of 1,582,287 shares, compared to its average volume of 1,479,601. The firm has a 50 day simple moving average of $1.88 and a 200 day simple moving average of $1.99. Cronos Group Inc. has a 52 week low of $1.60 and a 52 week high of $3.14. The firm has a market capitalization of $669.43 million, a price-to-earnings ratio of -13.46, a PEG ratio of 1.74 and a beta of 1.02.
About Cronos Group
(
Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Articles
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
